Package 58602-012-40

Brand: olopatadine hydrochloride

Generic: olopatadine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 58602-012-40
Digits Only 5860201240
Product NDC 58602-012
Product ID 58602-012_8fb16daa-340d-45a0-ab22-e028d77e2476
Description

1 BOTTLE, PLASTIC in 1 CARTON (58602-012-40) / 5 mL in 1 BOTTLE, PLASTIC

Marketing

Marketing Status
Marketed Since 2020-07-15
Brand olopatadine hydrochloride
Generic olopatadine hydrochloride
Sample Package No

Linked Drug Pages (1)

OLOPATADINE HYDROCHLORIDE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["OPHTHALMIC"], "spl_id": "8fb16daa-340d-45a0-ab22-e028d77e2476", "openfda": {"unii": ["2XG66W44KF"], "rxcui": ["1111339"], "spl_set_id": ["8fb16daa-340d-45a0-ab22-e028d77e2476"], "manufacturer_name": ["Aurohealth LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (58602-012-40)  / 5 mL in 1 BOTTLE, PLASTIC", "package_ndc": "58602-012-40", "marketing_start_date": "20200715"}], "brand_name": "OLOPATADINE HYDROCHLORIDE", "product_id": "58602-012_8fb16daa-340d-45a0-ab22-e028d77e2476", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Histamine Release [PE]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Inhibitor [EPC]"], "product_ndc": "58602-012", "generic_name": "OLOPATADINE HYDROCHLORIDE", "labeler_name": "Aurohealth LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "OLOPATADINE HYDROCHLORIDE", "active_ingredients": [{"name": "OLOPATADINE HYDROCHLORIDE", "strength": "1 mg/mL"}], "application_number": "ANDA204812", "marketing_category": "ANDA", "marketing_start_date": "20200715", "listing_expiration_date": "20261231"}